These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
905 related articles for article (PubMed ID: 30897321)
41. LncRNA MEG3 negatively modified osteosarcoma development through regulation of miR-361-5p and FoxM1. Shen B; Zhou N; Hu T; Zhao W; Wu D; Wang S J Cell Physiol; 2019 Aug; 234(8):13464-13480. PubMed ID: 30624782 [TBL] [Abstract][Full Text] [Related]
42. MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma. Liu S; Feng P Cell Physiol Biochem; 2015; 37(5):1956-66. PubMed ID: 26584294 [TBL] [Abstract][Full Text] [Related]
43. miR-17-5p promotes proliferation and epithelial-mesenchymal transition in human osteosarcoma cells by targeting SRC kinase signaling inhibitor 1. Zhao X; Xu Y; Sun X; Ma Y; Zhang Y; Wang Y; Guan H; Jia Z; Li Y; Wang Y J Cell Biochem; 2019 Apr; 120(4):5495-5504. PubMed ID: 30302813 [TBL] [Abstract][Full Text] [Related]
44. microRNA-16-5p suppresses cell proliferation and angiogenesis in colorectal cancer by negatively regulating forkhead box K1 to block the PI3K/Akt/mTOR pathway. Huang X; Xu X; Ke H; Pan X; Ai J; Xie R; Lan G; Hu Y; Wu Y Eur J Histochem; 2022 May; 66(2):. PubMed ID: 35536149 [TBL] [Abstract][Full Text] [Related]
45. LncRNA ADPGK-AS1 regulated cell proliferation, invasion, migration and apoptosis via targeting miR-542-3p in osteosarcoma. Luo XF; Wu XJ; Wei X; Wang AG; Wang SH; Wang JL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8751-8760. PubMed ID: 31696461 [TBL] [Abstract][Full Text] [Related]
46. Repression of lncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis. Li B; Lou G; Zhang J; Cao N; Yu X BMC Cancer; 2022 Jan; 22(1):124. PubMed ID: 35100978 [TBL] [Abstract][Full Text] [Related]
47. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma. Tan H; Zhao L J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482 [TBL] [Abstract][Full Text] [Related]
48. The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma. Li CF; Li YC; Wang Y; Sun LB Cell Physiol Biochem; 2018; 50(1):196-213. PubMed ID: 30278464 [TBL] [Abstract][Full Text] [Related]
49. Effects of MicroRNA-206 on Osteosarcoma Cell Proliferation, Apoptosis, Migration and Invasion by Targeting ANXA2 Through the AKT Signaling Pathway. Pan BL; Tong ZW; Wu L; Pan L; Li JE; Huang YG; Li SD; Du SX; Li XD Cell Physiol Biochem; 2018; 45(4):1410-1422. PubMed ID: 29462818 [TBL] [Abstract][Full Text] [Related]
50. RETRACTED: LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p. Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q Biomed Pharmacother; 2020 Feb; 122():109707. PubMed ID: 31918278 [TBL] [Abstract][Full Text] [Related]
51. miR-194 Suppresses Proliferation and Migration and Promotes Apoptosis of Osteosarcoma Cells by Targeting CDH2. Miao J; Wang W; Wu S; Zang X; Li Y; Wang J; Zhan R; Gao M; Hu M; Li J; Chen S Cell Physiol Biochem; 2018; 45(5):1966-1974. PubMed ID: 29518783 [TBL] [Abstract][Full Text] [Related]
52. Tanshinone I restrains osteosarcoma progression by regulating circ_0000376/miR-432-5p/BCL2 axis. Ye B; Qiao K; Zhao Q; Jiang Z; Hu N; Wang F Mol Cell Biochem; 2022 Jan; 477(1):1-13. PubMed ID: 34532813 [TBL] [Abstract][Full Text] [Related]
53. MicroRNA-340-5p inhibits the malignant phenotypes of osteosarcoma by directly targeting NRF2 and deactivating the PI3K/AKT pathway. Fan HP; Wang SY; Shi YY; Sun J Eur Rev Med Pharmacol Sci; 2021 May; 25(10):3661-3669. PubMed ID: 34109575 [TBL] [Abstract][Full Text] [Related]
54. LINC00612 functions as a ceRNA for miR-214-5p to promote the proliferation and invasion of osteosarcoma in vitro and in vivo. Zhou Y; Li X; Yang H Exp Cell Res; 2020 Jul; 392(1):112012. PubMed ID: 32311343 [TBL] [Abstract][Full Text] [Related]
55. MiR-671-5p plays a promising role in restraining osteosarcoma cell characteristics through targeting TUFT1. Ma C; Nie ZK; Guo HM; Kong Y J Biochem Mol Toxicol; 2020 Jul; 34(7):e22490. PubMed ID: 32115852 [TBL] [Abstract][Full Text] [Related]
56. Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma. Tian Q; Gu Y; Wang F; Zhou L; Dai Z; Liu H; Wu X; Wang X; Liu Y; Chen S; Han Q Biomed Pharmacother; 2020 Apr; 124():109884. PubMed ID: 32000044 [TBL] [Abstract][Full Text] [Related]
57. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells. Niu J; Sun Y; Guo Q; Niu D; Liu B Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493 [TBL] [Abstract][Full Text] [Related]
58. Circular RNA circ_0102049 promotes cell progression as ceRNA to target MDM2 via sponging miR-1304-5p in osteosarcoma. Jin Y; Li L; Zhu T; Liu G Pathol Res Pract; 2019 Dec; 215(12):152688. PubMed ID: 31727503 [TBL] [Abstract][Full Text] [Related]
59. MicroRNA-505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion. Liu YJ; Li W; Chang F; Liu JN; Lin JX; Chen DX Oncol Rep; 2018 Feb; 39(2):491-500. PubMed ID: 29251324 [TBL] [Abstract][Full Text] [Related]
60. Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis. Zhang R; Xia T Int J Oncol; 2017 Nov; 51(5):1460-1470. PubMed ID: 29048648 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]